Increasing evidence of potential toxicity of a common antibiotic combination

We read with interest the Al Yami et al. article concerning acute kidney injury (AKI) rates in patients on concomitant vancomycin and piperacillin –tazobactam (VPT) vs vancomycin (V) and merrem. Their retrospective cohort study showed an increased incidence of AKI in patients on combination antibiotic therapy [1].

Source: Journal of Infection and Public Health - July 28, 2017 Category: International Medicine & Public Health Authors: Morgan Scully, Ali Hassoun Tags: Letter to the Editor Source Type: research